Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care

OBJECTIVE: To examine long-term organ damage and safety following treatment with belimumab plus standard of care (SoC) in patients with systemic lupus erythematosus (SLE). METHODS: Pooled data were examined from two ongoing open-label studies that enrolled patients who completed BLISS-52 or BLISS-76...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, I N, Urowitz, M, van Vollenhoven, R, Aranow, C, Fettiplace, J, Oldham, M, Wilson, B, Molta, C, Roth, D, Gordon, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958991/
https://www.ncbi.nlm.nih.gov/pubmed/26936891
http://dx.doi.org/10.1177/0961203315625119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958991/
https://www.ncbi.nlm.nih.gov/pubmed/26936891
http://dx.doi.org/10.1177/0961203315625119

Ejemplares similares